as 07-04-2025 11:32am EST
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | FRIENDSWOOD |
Market Cap: | 456.2M | IPO Year: | 2019 |
Target Price: | $37.67 | AVG Volume (30 days): | 451.0K |
Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.18 | EPS Growth: | N/A |
52 Week Low/High: | $15.45 - $35.84 | Next Earning Date: | 08-04-2025 |
Revenue: | $347,083,000 | Revenue Growth: | 38.43% |
Revenue Growth (this year): | -9.66% | Revenue Growth (next year): | 1.36% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
MAETZOLD DEREK J | CSTL | Pres. & Chief Exec. Officer | Apr 21 '25 | Sell | $21.52 | 5,644 | $121,447.59 | 74,627 | |
MAETZOLD DEREK J | CSTL | Pres. & Chief Exec. Officer | Apr 8 '25 | Sell | $20.12 | 5,644 | $113,931.95 | 74,627 |
CSTL Breaking Stock News: Dive into CSTL Ticker-Specific Updates for Smart Investing
GlobeNewswire
18 days ago
MT Newswires
20 days ago
GlobeNewswire
20 days ago
GlobeNewswire
a month ago
GlobeNewswire
a month ago
GOBankingRates
a month ago
GOBankingRates
a month ago
GOBankingRates
a month ago
The information presented on this page, "CSTL Castle Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.